Evidence for eosinophil activation in cancer patients receiving recombinant interleukin-4: effects of interleukin-4 alone and following interleukin-2 administration.

Sosman JA, Bartemes K, Offord KP, Kita H, Fisher SG, Kefer C, Ellis TA, Fisher RI, Higgins TJ, Gleich GJ
Clin Cancer Res. 1995 1 (8): 805-12

PMID: 9816049

MeSH Terms (15)

Analysis of Variance Blood Proteins Cell Survival Dose-Response Relationship, Drug Eosinophil Granule Proteins Eosinophils Humans Interleukin-2 Interleukin-4 Leukocyte Count Neoplasms Recombinant Proteins Ribonucleases Skin Time Factors

Connections (1)

This publication is referenced by other Labnodes entities: